| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2024 | SAGE THERAPEUTICS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$170,000 | |
| 2024 | SAGE THERAPEUTICS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$120,000 | |
| 2024 | SAGE THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$140,000 | |
| 2024 | SAGE THERAPEUTICS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$140,000 | |
| 2023 | SAGE THERAPEUTICS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$110,000 | |
| 2023 | SAGE THERAPEUTICS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$140,000 | |
| 2023 | SAGE THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$130,000 | |
| 2023 | SAGE THERAPEUTICS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$130,000 | |
| 2022 | SAGE THERAPEUTICS |
4th Quarter (Oct 1 - Dec 31) AMENDED |
$110,000 | |
| 2022 | SAGE THERAPEUTICS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$110,000 |
| Firm | Filings | Expenses |
|---|---|---|
| SAGE THERAPEUTICS | 28 | $4,310,277 |
| Issue | Activities |
|---|---|
| Health Issues | 28 |
| Medicare/Medicaid | 23 |
| Copyright/Patent/Trademark | 2 |
| Budget/Appropriations | 2 |
| Pharmacy | 1 |
| Medical/Disease Research/Clinical Labs | 1 |
| Trade (domestic/foreign) | 1 |